Huiqin Lu

407 total citations
17 papers, 342 citations indexed

About

Huiqin Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Huiqin Lu has authored 17 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Huiqin Lu's work include Signaling Pathways in Disease (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Huiqin Lu is often cited by papers focused on Signaling Pathways in Disease (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Huiqin Lu collaborates with scholars based in China, Malaysia and United States. Huiqin Lu's co-authors include Xiaoying Lü, Zuhong Lu, Yan Huang, Yinghua Qu, Siyu Zeng, Ling Gao, Xuping Qin, Lifeng Zhao, Yamin Yang and Pengke Yan and has published in prestigious journals such as Biomaterials, Annals of Oncology and European Journal of Pharmacology.

In The Last Decade

Huiqin Lu

14 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiqin Lu China 8 95 92 80 41 27 17 342
Hongxia Li China 10 109 1.1× 90 1.0× 79 1.0× 20 0.5× 37 1.4× 17 372
Yao Wu China 12 125 1.3× 92 1.0× 63 0.8× 19 0.5× 21 0.8× 32 419
Parya Aghasafari United States 8 39 0.4× 117 1.3× 27 0.3× 23 0.6× 52 1.9× 14 423
Kexin Cui China 10 20 0.2× 117 1.3× 54 0.7× 41 1.0× 19 0.7× 25 389
Binhui Wang China 13 72 0.8× 145 1.6× 118 1.5× 20 0.5× 7 0.3× 27 454
Baozhu Wang China 11 25 0.3× 134 1.5× 37 0.5× 83 2.0× 44 1.6× 39 505

Countries citing papers authored by Huiqin Lu

Since Specialization
Citations

This map shows the geographic impact of Huiqin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqin Lu more than expected).

Fields of papers citing papers by Huiqin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiqin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqin Lu. The network helps show where Huiqin Lu may publish in the future.

Co-authorship network of co-authors of Huiqin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiqin Lu. A scholar is included among the top collaborators of Huiqin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiqin Lu. Huiqin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
3.
4.
Chen, Yan, et al.. (2024). Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model. European Journal of Pharmacology. 969. 176429–176429. 5 indexed citations
5.
Lu, Huiqin, et al.. (2024). Prostate cancer stem cells: an updated mini-review. Journal of Cancer. 15(20). 6570–6576.
7.
Shen, Qi, Huiqin Lu, Jielin Zhang, et al.. (2024). Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer. Discover Oncology. 15(1). 822–822. 1 indexed citations
9.
Lu, Huiqin, et al.. (2020). 359P The role of adjuvant targeted therapy for postoperative EGFR mutant non-small cell lung cancer: A network meta-analysis. Annals of Oncology. 31. S1379–S1379. 2 indexed citations
11.
Zeng, Siyu, et al.. (2019). Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway. Journal of Cellular and Molecular Medicine. 23(6). 4196–4207. 28 indexed citations
14.
Zeng, Siyu, et al.. (2018). Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells. Mediators of Inflammation. 2018. 1–10. 11 indexed citations
15.
Zeng, Siyu, et al.. (2018). Protein Arginine Methyltransferase 2 Inhibits Angiotensin II-Induced Proliferation and Inflammation in Vascular Smooth Muscle Cells. BioMed Research International. 2018. 1–8. 15 indexed citations
16.
Lü, Xiaoying, Huiqin Lu, Lifeng Zhao, Yamin Yang, & Zuhong Lu. (2010). Genome-wide pathways analysis of nickel ion-induced differential genes expression in fibroblasts. Biomaterials. 31(8). 1965–1973. 37 indexed citations
17.
Lü, Xiaoying, et al.. (2008). Mechanisms of cytotoxicity of nickel ions based on gene expression profiles. Biomaterials. 30(2). 141–148. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026